{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ASP Isotopes Inc."},"Symbol":{"label":"Symbol","value":"ASPI"},"Address":{"label":"Address","value":"United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Major Chemicals"},"Sector":{"label":"Sector","value":"Industrials"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida."},"CompanyUrl":{"label":"Company Url","value":"https://www.aspisotopes.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Hendrik Strydom","title":"Director & Chief Technology Officer"},{"name":"Paul E. Mann","title":"Chairman, Chief Executive Officer & Secretary"},{"name":"Robert Ainscow","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}